ANTICOV was designed as an ‘adaptive platform trial’ to enable rapid and flexible decisions as we gather knowledge on treatment for mild to moderate COVID-19 cases in Africa. But what is an adaptive platform trial? Dr Roger Lewis answers in this short video.
